Your browser doesn't support javascript.
loading
Economic burden for Alzheimer's disease in China from 2010 to 2050: a modelling study.
Clay, Emilie; Zhou, Junwen; Yi, Zhan-Miao; Zhai, Suodi; Toumi, Mondher.
Affiliation
  • Clay E; Health Economics and Outcomes Research Department, Creativ-Ceutical, Paris, France.
  • Zhou J; Public Health Department - Research Unit EA 3279, Aix-Marseille University, Marseille, France.
  • Yi ZM; Department of Pharmacy, Peking University Third Hospital, Beijing, China.
  • Zhai S; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Science, Peking University Health Science Center, Beijing, China.
  • Toumi M; Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China.
J Mark Access Health Policy ; 7(1): 1667195, 2019.
Article in En | MEDLINE | ID: mdl-31595183
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Language: En Journal: J Mark Access Health Policy Year: 2019 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Language: En Journal: J Mark Access Health Policy Year: 2019 Document type: Article Affiliation country: Country of publication: